• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.63%

    Athersys, Inc. (ATHX)

    -NasdaqCM
    1.23 Down 0.06(4.65%) Apr 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.29
    Open:1.28
    Bid:1.22 x 2600
    Ask:1.42 x 2000
    1y Target Est:5.50
    Beta:-0.02
    Next Earnings Date:11-May-15ATHX Earnings announcement
    Day's Range:1.21 - 1.28
    52wk Range:0.90 - 3.43
    Volume:1,807,388
    Avg Vol (3m):2,075,640
    Market Cap:98.69M
    P/E (ttm):N/A
    EPS (ttm):-0.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ATHX

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):63.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.31
    Quarterly EPS Est (Mar-15) :-0.09
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-0.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback